Asia-Pacific Anti-Nuclear Antibody Test Market forecast analysis & country data.

Databridge4317 Oct, 2022Other

Data Bridge Market Research analyses that the anti-nuclear antibody test will exhibit a CAGR of around 12.95% for the forecast period of 2022-2029. Increasing prevalence of chronic and autoimmune diseases across the world, continuous attempts being made to embrace the best vaccines, growing number of clinical trials for vaccines,